This topic contains a solution. Click here to go to the answer

Author Question: The client has started to take orlistat (Alli) as a part of a weight-loss management program. Which ... (Read 35 times)

jayhills49

  • Hero Member
  • *****
  • Posts: 559
The client has started to take orlistat (Alli) as a part of a weight-loss management program. Which preexisting health condition(s), if present, would make this medication contraindicated?
 
  Standard Text: Select all that apply.
  1. Depression treated with monoamine oxidase inhibitors (MAOIs)
  2. Cholestasis
  3. BMI greater than 40
  4. Heart disease and dysrhythmias
  5. Bulimia and anorexia nervosa

Question 2

The nurse is reviewing medications that have been proven effective for weight loss. Which medications does the nurse identify as being removed from the market due to safety concerns?
 
  Standard Text: Select all that apply.
  1. Amphetamine and dextroamphetamine (Dexedrine)
  2. Orlistat (Alli)
  3. Fenfluramine and phentermine (Fen-Phen)
  4. Ephedra alkaloids
  5. Sibutramine (Meridia)



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Eunice618

  • Sr. Member
  • ****
  • Posts: 350
Answer to Question 1

Thanks for your help Worked like a charm.

Answer to Question 2

Correct Answer: 3,4,5
Rationale 1: Although these medications are highly addictive and rarely prescribed for weight loss, they have not been pulled from the market due to safety issues.
Rationale 2: Orlistat (Alli) is an over-the-counter (OTC) medication that is still available for use to aide a weight-loss program.
Rationale 3: Fenfluramine was removed from the market for causing heart valve defects.
Rationale 4: Ephedra alkaloids have been removed from the market due to an increased incidence of adverse cardiovascular events.
Rationale 5: Sibutramine (Meridia) was voluntarily withdrawn from the U.S. market due to an increased risk of heart attacks and strokes.
Global Rationale: Fenfluramine was removed from the market for causing heart valve defects. Ephedra alkaloids have been removed from the market due to an increased incidence of adverse cardiovascular events. Sibutramine (Meridia) was voluntarily withdrawn from the U.S. market due to an increased risk of heart attacks and strokes. Although these medications are highly addictive and rarely prescribed for weight loss, they have not been pulled from the market due to safety issues. Orlistat (Alli) is an over-the-counter (OTC) medication that is still available for use to aide a weight-loss program




jayhills49

  • Member
  • Posts: 559
Reply 2 on: Jul 23, 2018
Gracias!


mohan

  • Member
  • Posts: 362
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

The most common treatment options for addiction include psychotherapy, support groups, and individual counseling.

Did you know?

The Romans did not use numerals to indicate fractions but instead used words to indicate parts of a whole.

Did you know?

In the United States, congenital cytomegalovirus causes one child to become disabled almost every hour. CMV is the leading preventable viral cause of development disability in newborns. These disabilities include hearing or vision loss, and cerebral palsy.

Did you know?

Acute bronchitis is an inflammation of the breathing tubes (bronchi), which causes increased mucus production and other changes. It is usually caused by bacteria or viruses, can be serious in people who have pulmonary or cardiac diseases, and can lead to pneumonia.

Did you know?

Russia has the highest death rate from cardiovascular disease followed by the Ukraine, Romania, Hungary, and Poland.

For a complete list of videos, visit our video library